These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33316324)

  • 1. Pharmacogenetics of antipsychotics: Clinical utility and implementation.
    Arranz MJ; Salazar J; Hernández MH
    Behav Brain Res; 2021 Mar; 401():113058. PubMed ID: 33316324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.
    Hernandez M; Cullell N; Cendros M; Serra-Llovich A; Arranz MJ
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.
    Korošec Hudnik L; Blagus T; Redenšek Trampuž S; Dolžan V; Bon J; Pjevac M
    Front Psychiatry; 2024; 15():1363051. PubMed ID: 38566958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments.
    Arranz MJ; Gonzalez-Rodriguez A; Perez-Blanco J; Penadés R; Gutierrez B; Ibañez L; Arias B; Brunet M; Cervilla J; Salazar J; Catalan R
    Transl Psychiatry; 2019 Jul; 9(1):177. PubMed ID: 31346157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.
    Teng Y; Sandhu A; Liemburg EJ; Naderi E; Alizadeh BZ
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
    Jameson A; Faisal M; Fylan B; Bristow GC; Sohal J; Dalton C; Sagoo GS; Cardno AG; McLean SL
    J Psychopharmacol; 2024 Apr; 38(4):382-394. PubMed ID: 38494658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
    Murray M
    J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
    Ravyn D; Ravyn V; Lowney R; Nasrallah HA
    Schizophr Res; 2013 Sep; 149(1-3):1-14. PubMed ID: 23870808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring pharmacogenetic variation in a Bulgarian psychiatric cohort.
    Ivanov HY; Velinov B; Kyosovksa G; Grigorova D; Shopov P
    Folia Med (Plovdiv); 2021 Jun; 63(3):365-371. PubMed ID: 34196139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics can improve antipsychotic treatment in schizophrenia.
    Xu Q; Wu X; Xiong Y; Xing Q; He L; Qin S
    Front Med; 2013 Jun; 7(2):180-90. PubMed ID: 23606027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.
    Elsheikh SSM; Müller DJ; Pouget JG
    Methods Mol Biol; 2022; 2547():389-425. PubMed ID: 36068471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].
    Kirnichnaya KA; Sosin DN; Ivanov MV; Mikhaylov VA; Ivashchenko DV; Ershov EE; Taraskina AE; Nasyrova RF; Krupitsky EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):113-125. PubMed ID: 26322366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of response to antipsychotics in patients with schizophrenia.
    Arranz MJ; Rivera M; Munro JC
    CNS Drugs; 2011 Nov; 25(11):933-69. PubMed ID: 22054119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of second-generation antipsychotics.
    Brennan MD
    Pharmacogenomics; 2014 Apr; 15(6):869-84. PubMed ID: 24897292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):9-37. PubMed ID: 21162693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics and antipsychotic treatment response.
    Naumovska Z; Nestorovska AK; Filipce A; Sterjev Z; Brezovska K; Dimovski A; Suturkova LJ
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):53-67. PubMed ID: 26076775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of clinical response to risperidone.
    Llerena A; Berecz R; Peñas-Lledó E; Süveges A; Fariñas H
    Pharmacogenomics; 2013 Jan; 14(2):177-94. PubMed ID: 23327578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.